Welcome to our dedicated page for Nuwellis news (Ticker: NUWE), a resource for investors and traders seeking the latest updates and insights on Nuwellis stock.
Nuwellis Inc (NUWE) is a leader in developing medical devices for fluid overload management and renal monitoring. This page serves as the definitive source for verified news and official announcements about the company’s innovations in critical care technology.
Access real-time updates on Aquadex SmartFlow System deployments, RenalSense Clarity RMS clinical validations, and strategic partnerships. Investors and healthcare professionals will find essential information about regulatory milestones, research findings, and operational developments directly impacting patient care standards.
Our curated collection includes earnings reports, product launch details, and peer-reviewed study outcomes. All content is rigorously verified to ensure accuracy while maintaining accessibility for both medical experts and general investors.
Bookmark this page for streamlined access to NUWE’s latest advancements in ultrafiltration therapy and kidney function monitoring technologies. Return regularly to stay informed about developments shaping the future of fluid management solutions.
Nuwellis, Inc. (Nasdaq: NUWE) has received a Notice of Allowance from the USPTO for a patent related to its innovative pediatric Continuous Renal Replacement Therapy (CRRT) device Vivian™. This patent enhances Nuwellis' IP portfolio, enabling healthcare providers to seamlessly switch between stationary and transport modes for improved patient care. The company is also developing a new pediatric CRRT device with NIH funding, in collaboration with Koronis Biomedical Technologies , to better care for children with kidney issues.
Nuwellis, Inc. announced the closing of a $2.7 million public offering, issuing 11,250,000 shares of common stock and warrants. The gross proceeds will be used for working capital and general corporate purposes, including investments in commercialization efforts.
Nuwellis, Inc. (NUWE) will report its first quarter 2024 financial results on May 7, 2024. The medical technology company will host a conference call and webcast to discuss the results and provide a business update.
FAQ
What is the current stock price of Nuwellis (NUWE)?
What is the market cap of Nuwellis (NUWE)?
